{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:52:29Z","timestamp":1775767949106,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:p>The prognostic role of the angiotensin-converting enzyme (<jats:italic toggle=\"yes\">ACE<\/jats:italic>) insertion\/deletion (I\/D) genetic polymorphism in patients with acute myocardial infarction (AMI) is controversial and inconsistent across various study populations. This study evaluated the predictive validity of the <jats:italic toggle=\"yes\">ACE<\/jats:italic> I\/D variant based on 12-month all-cause mortality in Vietnamese patients after AMI. This was an observational, prospective study conducted among AMI patients at Cho Ray Hospital between January 2020 and September 2021. All participants were identified for <jats:italic toggle=\"yes\">ACE<\/jats:italic> I\/D polymorphism using the polymerase chain reaction method, with follow-up on survival status at 12 months from the date of admission. The proportions of II, ID, and DD genotypes of the <jats:italic toggle=\"yes\">ACE<\/jats:italic> I\/D variant were 49.5%, 35.9%, and 14.6%, respectively. All-cause mortality after 12 months occurred in 58 cases (10.6%). The <jats:italic toggle=\"yes\">ACE<\/jats:italic> I\/D polymorphism did not affect all-cause mortality in the dominant (<jats:italic toggle=\"yes\">P<\/jats:italic> = .196), recessive (<jats:italic toggle=\"yes\">P<\/jats:italic> = .827), homozygous (<jats:italic toggle=\"yes\">P<\/jats:italic> = .515), and heterozygous (<jats:italic toggle=\"yes\">P<\/jats:italic> = .184) models. A subgroup analysis by usage status of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker (ACEI\/ARB) showed that in the non-ACEI\/ARB group, patients with the DD genotype had a lower cumulative survival probability than patients with the II\/ID genotypes (hazard ratio [HR] = 3.97, 95% confidence interval [CI]: 1.21\u201313.04; <jats:italic toggle=\"yes\">P<\/jats:italic> = .023). Among patients with Global Registry of Acute Coronary Events (GRACE) scores below the median (153.5 points), those with DD genotype had a higher risk of mortality than those with the II\/ID genotypes (HR = 3.35, 95% CI: 1.01\u201311.11; <jats:italic toggle=\"yes\">P<\/jats:italic> = .049). The <jats:italic toggle=\"yes\">ACE<\/jats:italic> I\/D genetic polymorphism was found not to be associated with 12-month all-cause mortality in Vietnamese patients with AMI. However, it was associated with mortality in patients who did not use ACEI\/ARB and also whose GRACE scores were below 153.5 points.<\/jats:p>","DOI":"10.1097\/md.0000000000034976","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:06:31Z","timestamp":1693602391000},"page":"e34976","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Predictive value of ACE I\/D genetic polymorphism for 12-month all-cause mortality in patients with acute myocardial infarction"],"prefix":"10.1097","volume":"102","author":[{"given":"Duy Cong","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Department of Cardiology, Cho Ray Hospital, Ho Chi Minh City, Vietnam"},{"name":"Cardiovascular Center, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9997-6390","authenticated-orcid":false,"given":"Minh Duc","family":"Do","sequence":"additional","affiliation":[{"name":"Center for Molecular Biomedicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linh Hoang Gia","family":"Le","sequence":"additional","affiliation":[{"name":"Center for Molecular Biomedicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Truc Thanh","family":"Thai","sequence":"additional","affiliation":[{"name":"Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sy Van","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Department of Cardiology, Cho Ray Hospital, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binh Quang","family":"Truong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Cardiovascular Center, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijpvm.IJPVM_122_20","article-title":"The reduction of mortality in acute myocardial infarction: from bed rest to future directions.","volume":"13","author":"Laforgia","year":"2022","journal-title":"Int J Prev Med"},{"key":"R3-20250504","first-page":"101228","article-title":"Coronary artery disease in South Asian patients: cardiovascular risk factors, pathogenesis and treatments.","volume":"00","author":"Sucato","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.","volume":"42","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"473","DOI":"10.32604\/biocell.2023.025930","article-title":"Biochemical association between the prevalence of genetic polymorphism and myocardial infarction.","volume":"47","author":"Shahid","year":"2023","journal-title":"Biocell"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-5273(99)00064-9","article-title":"D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction.","volume":"70","author":"Yoshida","year":"1999","journal-title":"Int J Cardiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2143\/AC.56.6.2005698","article-title":"Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction.","volume":"56","author":"Tokunaga","year":"2001","journal-title":"Acta Cardiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0735-1097(02)02927-3","article-title":"Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.","volume":"41","author":"Palmer","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2350-8-27","article-title":"Renin-angiotensin-aldosterone system polymorphism: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.","volume":"8","author":"Franco","year":"2007","journal-title":"BMC Med Genet"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2261-12-6","article-title":"Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study.","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Cardiovas Disord"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gtmb.2009.0105","article-title":"Angiotensin-converting enzyme insertion\/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population.","volume":"14","author":"Mehri","year":"2010","journal-title":"Genet Test Mol Biomarkers"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/359641a0","article-title":"Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.","volume":"359","author":"Cambien","year":"1992","journal-title":"Nature"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"19719","DOI":"10.1038\/s41598-019-56263-8","article-title":"Associations of ACE I\/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients.","volume":"9","author":"Dai","year":"2019","journal-title":"Sci Rep"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets.","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp Eye Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0735-1097(96)00139-8","article-title":"Insertion\/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.","volume":"28","author":"Samani","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(00)82009-7","article-title":"Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion\/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls.","volume":"355","author":"Keavney","year":"2000","journal-title":"Lancet"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000084592","article-title":"Lack of association between common polymorphisms in genes of the renin-angiotensin system and mortality after myocardial infarction.","volume":"103","author":"Andrikopoulos","year":"2005","journal-title":"Cardiology"},{"key":"R19-20250504","first-page":"100701","article-title":"Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction.","volume":"32","author":"Moorthy","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction.","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease.","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"R22-20250504","first-page":"e004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? derivation, external validation, and outcomes using the updated GRACE risk score.","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1091612","DOI":"10.3389\/fcvm.2023.1091612","article-title":"Association between ACE I\/D genetic polymorphism and the severity of coronary artery disease in Vietnamese patients with acute myocardial infarction.","volume":"10","author":"Tran","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R24-20250504","first-page":"215","article-title":"Spectrum of mutations in the RB1 gene in Vietnamese patients with retinoblastoma.","volume":"25","author":"Kiet","year":"2019","journal-title":"Mol Vis"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ijlh.13345","article-title":"Recurrent PROC and novel PROS1 mutations in Vietnamese patients diagnosed with idiopathic deep venous thrombosis.","volume":"43","author":"Do","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.","volume":"124","author":"McManus","year":"2011","journal-title":"Am J Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/DMSO.S347830","article-title":"Association of ADIPOQ single-nucleotide polymorphisms with the two clinical phenotypes type 2 diabetes mellitus and metabolic syndrome in a kinh Vietnamese population.","volume":"15","author":"Truong","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e31653","DOI":"10.1097\/MD.0000000000031653","article-title":"Association of KCNJ11 and ABCC8 single-nucleotide polymorphisms with type 2 diabetes mellitus in a Kinh Vietnamese population.","volume":"101","author":"Tran","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"608948","DOI":"10.3389\/fcvm.2021.608948","article-title":"Association between AGT M235T and left ventricular mass in vietnamese patients diagnosed with essential hypertension.","volume":"8","author":"Tran","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1067\/mhj.2000.106165","article-title":"Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up.","volume":"139","author":"Brscic","year":"2000","journal-title":"Am Heart J"},{"key":"R31-20250504","first-page":"211","article-title":"Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease.","volume":"87","author":"Evans","year":"1994","journal-title":"Q J Med"},{"key":"R32-20250504","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure.","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. results of the survival and ventricular enlargement trial. The SAVE investigators.","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12872-021-02070-x","article-title":"Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).","volume":"21","author":"Kim","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.HYP.0000239204.41079.6b","article-title":"Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events.","volume":"48","author":"Goldenberg","year":"2006","journal-title":"Hypertension"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1536\/ihj.13-288","article-title":"Renin-angiotensin-aldosterone system polymorphism and 5-year mortality in survivors of acute myocardial infarction.","volume":"55","author":"Hara","year":"2014","journal-title":"Int Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:12:12Z","timestamp":1746324732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":36,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034976","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}